Moderna MRNA
NASDAQ MRNA
$254.19 +12.73 (+5.27%)
At close: Nov 6, 2026 · 4:00 PM EST

Moderna (MRNA) Total Debt (2025 - 2026)

Updated

Moderna's Total Debt came in at $591 million for Q2 2026, up 0.2% from the prior quarter.

Analysis

Moderna (MRNA) Total Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Moderna's Total Debt was $590 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 44.65 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 80.90 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -11.96 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 26.23 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 62.67 Bn
10 Moderna 100.92 Bn 80.27 Bn 52.00 Mn 591.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 591.00 Mn
Mar 31, 2026 590.00 Mn
Dec 31, 2025 590.00 Mn
API Access

Moderna Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=MRNA&period=max&api_key=YOUR_API_KEY